about
Lipid nanoparticles for targeted siRNA delivery - going from bench to bedsideMicroneedles As a Delivery System for Gene TherapyIn Vivo Delivery Systems for Therapeutic Genome EditingProduction and clinical development of nanoparticles for gene deliveryTowards Targeted Delivery Systems: Ligand Conjugation Strategies for mRNA Nanoparticle Tumor VaccinesBone site-specific delivery of siRNANeuroprotective therapies in glaucoma: II. Genetic nanotechnology toolsObesity genetics in mouse and human: back and forth, and back againCell-based therapy technology classifications and translational challengessiRNA Versus miRNA as Therapeutics for Gene SilencingGene delivery strategies to promote spinal cord repairInducing brain regeneration from within: in vivo reprogramming of endogenous somatic cells into neuronsQuaking promotes monocyte differentiation into pro-atherogenic macrophages by controlling pre-mRNA splicing and gene expression.Gene delivery polymer structure-function relationships elucidated via principal component analysis.Delivery of RNAi Therapeutics to the Airways-From Bench to BedsideRetroviral vectors and transposons for stable gene therapy: advances, current challenges and perspectivesDeveloping miRNA therapeutics for cardiac repair in ischemic heart diseaseHDL as a drug and nucleic acid delivery vehicleLiver-targeted gene therapy: Approaches and challengesTissue engineering for bone regeneration and osseointegration in the oral cavityTherapeutic genome editing: prospects and challengesTechnologies for controlled, local delivery of siRNAPathogen- and Host-Directed Antileishmanial Effects Mediated by Polyhexanide (PHMB)Rapid Exchange Between Free and Bound States in RNA-Dendrimer Polyplexes: Implications on the Mechanism of Delivery and ReleaseEfficient delivery of DNA into bovine preimplantation embryos by multiwall carbon nanotubesPolyion complex (PIC) particles: Preparation and biomedical applicationsScreening of efficient siRNA carriers in a library of surface-engineered dendrimersBarriers to inhaled gene therapy of obstructive lung diseases: A reviewNovel delivery approaches for cancer therapeutics.Kidney-specific Sonoporation-mediated Gene Transfer.Patient-Specific Therapy via Cell-Reprogramming Technology: a Curative Potential for Patients with DiabetesPhysicochemical and biological characterization of chitosan-microRNA nanocomplexes for gene delivery to MCF-7 breast cancer cellsRaster image cross-correlation analysis for spatiotemporal visualization of intracellular degradation activities against exogenous DNAs.Trends in the Binding of Cell Penetrating Peptides to siRNA: A Molecular Docking Study.Multifaceted Applications of Chitosan in Cancer Drug Delivery and Therapy.Cell-derived vesicles for drug therapy and diagnostics: opportunities and challenges.The Hippo pathway in tissue homeostasis and regeneration.Low-Dose Gene Therapy for Murine PKU Using Episomal Naked DNA Vectors Expressing PAH from Its Endogenous Liver PromoterTherapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivoMultifunctional Nucleus-targeting Nanoparticles with Ultra-high Gene Transfection Efficiency for In Vivo Gene Therapy
P2860
Q26741449-942173FC-0A3B-483B-82AA-F33C47AC0EADQ26746026-A741DE06-4496-4E48-B68E-E534423D00B3Q26748886-D0A431B6-AA33-4FA7-B061-3F1E37565ABBQ26752803-DB30F03F-D415-41AB-B9BA-F099C7549996Q26773073-5C425A8F-A46A-44AD-881C-CE83B2D31B02Q26773973-6882E874-99F0-4D12-85A2-F21EB1A4FA75Q26777286-5004119C-C158-4E17-9EEE-AEE8842239CDQ26782027-056BFC73-796B-48D0-8305-12FE3223206FQ26785346-B4707BED-3671-4FB8-851B-32DC3BDF3FB1Q26786876-BEC21ADB-66AA-418D-AE8D-BF1B90F821E0Q26825131-676B5788-D776-4A2F-AAED-080B668CCE81Q27025649-80352929-8052-43BC-A8DF-9C16BB04EB32Q27328830-567F045E-9D47-4DE7-971C-5481BB2DCC7BQ27334929-73E60C86-E038-4878-81C3-63FA30EA3A35Q28067306-E2720396-52C5-4BB4-A579-1BCF8BF549DCQ28074002-80553365-E791-4EA4-A2E0-86985F2011D4Q28077986-9FF709E3-46D3-4A08-99C1-EEA4A8CDC012Q28083209-2349D1AC-88DE-4ABD-A8DD-928987D05B79Q28085748-A42DC158-11E6-43B0-8332-E0A8A6166094Q28087194-B392137A-AC44-495F-90B9-4A56A4AE690DQ28087380-D4A3899A-5A6F-442E-8F29-7D389E176E0DQ28087657-2E36206E-BDAC-4798-9D01-2944A3FB5845Q28550034-57C22AF8-CD82-4915-9EDB-A7D98847E737Q28821628-5C6D7FFD-D0C0-4208-9FF1-C23232B405E7Q28829918-9D04F04D-184F-48BA-A8AF-AFAA1168215CQ28831355-B38AA707-78B6-4101-AB57-5E939899E6C6Q28834046-B5B83C89-39EB-4C7A-95C3-6F20C0CC164EQ29248141-0BEB5542-5C40-4AEF-A32B-906C03140A9BQ30368171-EF374BF9-C3F1-41C4-B6D0-4468002F4A34Q30389264-4B032239-2AC8-4A78-AA24-5950B7FD9ABDQ30394255-679CDA3A-0EE7-4B65-AD80-46CEAFB39B78Q30663038-A7FC273A-C6F3-4882-A16E-E5B2080419D1Q30665945-E945390C-18CD-43DC-9627-B8A98E7E0E36Q30840924-3047EE94-F6F4-4CD7-B103-114FF7A19384Q33612179-960AC586-D191-4061-9F62-BEC828CA40D8Q33615785-CF359A3E-3C11-4EBD-8F8F-1524C9264638Q33628097-C3384A35-FDB3-4E9C-981E-E1E399B23746Q33652430-F9D044B2-93C6-43AE-9CF1-FE3C114DDA62Q33652566-47A7B4B1-A7B3-4549-8A93-00E6EB950578Q33703111-0B0060D8-27C6-40DF-B6C0-28ABD02BBAD6
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Non-viral vectors for gene-based therapy.
@ast
Non-viral vectors for gene-based therapy.
@en
Non-viral vectors for gene-based therapy.
@nl
type
label
Non-viral vectors for gene-based therapy.
@ast
Non-viral vectors for gene-based therapy.
@en
Non-viral vectors for gene-based therapy.
@nl
prefLabel
Non-viral vectors for gene-based therapy.
@ast
Non-viral vectors for gene-based therapy.
@en
Non-viral vectors for gene-based therapy.
@nl
P2093
P356
P1476
Non-viral vectors for gene-based therapy.
@en
P2093
Ahmed A Eltoukhy
Arturo J Vegas
Daniel G Anderson
J Robert Dorkin
Rosemary L Kanasty
P2888
P304
P356
10.1038/NRG3763
P577
2014-07-15T00:00:00Z
P5875
P6179
1022388063